Abstract
We describe 24 consecutive patients with cervical cancer stage III or IV who received palliative urinary diversion by percutaneous nephrostomy. All patients had proven malignant ureteric obstruction, uremia and failed ureteric stenting. 11 of 17 patients with extensive primary cancer and local lymph node involvement had an acceptable quality of life for 2 or more months while the mean survival was 5.6 months. Patients with disseminated metastasizing cancer were not satisfactorily served by nephrostomy.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Barton DP, Morse SS, Fiorica JV, Hoffmann, MS, Roberts WS, Cavanagh D (1992) Percutaneous nephrostomy and ureteral stenting in gynecological malignancies. Obstet Gynecol 80:805–811
Chan S, Robinson AC, Johnson RJ (1990) Percutaneous nephrostomy: its value in obstructive uropathy complicating carcinoma of cervix uteri. Clin Oncol 2:156–158
Dudley BS, Gershenson DM, Kavanagh JJ, Copeland LJ, Carrasco CH, Rutledge FN (1986) Percutaneous nephrostomy catheter use in gynecologic malignancy: M.D. Anderson Hospital experience. Gynecol Oncol 24:273–278
Eisenmenger M, Höbarth K, Hofbauer H, Marberger M (1993) Palliative Harnableitung beim terminalen gynäkologischen Karzinom mit postrenaler Niereninsuffizienz? Acta Chir Austriacea 25:9–40
Feuer GA, Fruchter R, Seruri E, Maiman R, Remy JC, Boyce JG (1991) Selection for percutaneous nephrostomy in gynecologic cancer patients. Gynecol Oncol 42:60–63
Fourier G, Delaviere D, Le Coat R, Philippe P, Mangin P (1994) La nephrostomie percutanee de drainage chez le patient age de plus de 70 ans. A propros de 98 nephrostomies chez 74 patients. Prog. Urol 4:362–370
Gadduchi A, Madrigali A, Facchini V, Fioretti P (1994) Percutaneous nephrostomy in patients with advanced or recurrent cervical cancer. Clin Exp Obstet Gynecol 21:71–73
Harrington KJ, Pandha HS, Kelly SA, Lambert HE, Jackson JE, Waxman J (1995) Palliation of obstructive nephropathy due to malignancy. Br J Urol 76:101–107
Heedegaard CK, Wallace D (1987) Percutaneous nephrostomy: current indications and potential uses in obstetrics and gynecology. Obstet Gynecol Surv 42:571–675
Holden S, McPhee M, Grabstald H (1979) The rationale of urinary diversion in cancer patients. J Urol 121:19–21
Inoue K, Sakai M, Kanou M, Oda H, Kitahara K, Kanamura M, Osaka M, Yokohama M (1994) Endourologic treatment of the upper urinary tract obstruction in the advanced cancer patients. Nippon Hinyokika Gakkai Zasshi 85:806–810
Janatschek G, Mack D, Hetzel H (1988) Urinary diversion in gynecological malignancies. Eur Urol 14:371–376
Lee SK, Jones HW (1994) Prognostic significance of ureteral obstruction in primary cervical cancer. Int J Gynecol 44:59–65
Lingam K, Peterson PJ, Lingam MK, Buckley JF, Forrester A (1994) Subcutaneous urinary diversion: an alternative to percutaneous nephrostomy. J Urol 152:70–72
Losinno F, Pavlica P, Mami A, Mattioli R, Poggi C (1991) Percutaneous nephrostomy in neoplasm patients: when? Radiol Med (Torino) 82:829–832
Nakada SY, Gerber AJ, Wolf JS, Hicks ME, Picus D, Clayman RV (1995) Subcutaneous urinary diversion utilizing a nephrovesical stent: a superior alternative to long-term external drainage? Urology 45:538–541
Nielsen OS, Grossmann E (1990) Ultrasonically guided percutaneous nephrostomy. Scand J Urol Nephrol 24:219–221
Pedersen H, Juul N (1988) Ultrasound-guided percutaneous nephrostomy in the treatment of advanced gynecological malignancy. Acta Obstet Gynecol Scand 67:199–201
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Emmert, C., Raßler, J. & Köhler, U. Survival and quality of life after percutaneous nephrostomy for malignant ureteric obstruction in patients with terminal cervical cancer. Arch Gynecol Obstet 259, 147–151 (1997). https://doi.org/10.1007/BF02505324
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02505324